Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study.
Aged
Atrial Fibrillation
/ diagnosis
Female
Genome-Wide Association Study
/ methods
Humans
Hyperthyroidism
/ blood
Hypothyroidism
/ blood
Iodide Peroxidase
/ immunology
Male
Mendelian Randomization Analysis
/ methods
Middle Aged
Polymorphism, Single Nucleotide
Risk Factors
Thyroid Function Tests
/ methods
Thyroid Gland
/ metabolism
Thyrotropin
/ blood
Thyroxine
/ blood
Triiodothyronine
/ blood
White People
/ genetics
Journal
JAMA cardiology
ISSN: 2380-6591
Titre abrégé: JAMA Cardiol
Pays: United States
ID NLM: 101676033
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
pubmed:
24
1
2019
medline:
1
2
2020
entrez:
24
1
2019
Statut:
ppublish
Résumé
Increased free thyroxine (FT4) and decreased thyrotropin are associated with increased risk of atrial fibrillation (AF) in observational studies, but direct involvement is unclear. To evaluate the potential direct involvement of thyroid traits on AF. Study-level mendelian randomization (MR) included 11 studies, and summary-level MR included 55 114 AF cases and 482 295 referents, all of European ancestry. Genomewide significant variants were used as instruments for standardized FT4 and thyrotropin levels within the reference range, standardized triiodothyronine (FT3):FT4 ratio, hypothyroidism, standardized thyroid peroxidase antibody levels, and hyperthyroidism. Mendelian randomization used genetic risk scores in study-level analysis or individual single-nucleotide polymorphisms in 2-sample MR for the summary-level data. Prevalent and incident AF. The study-level analysis included 7679 individuals with AF and 49 233 referents (mean age [standard error], 62 [3] years; 15 859 men [29.7%]). In study-level random-effects meta-analysis, the pooled hazard ratio of FT4 levels (nanograms per deciliter) for incident AF was 1.55 (95% CI, 1.09-2.20; P = .02; I2 = 76%) and the pooled odds ratio (OR) for prevalent AF was 2.80 (95% CI, 1.41-5.54; P = .003; I2 = 64%) in multivariable-adjusted analyses. The FT4 genetic risk score was associated with an increase in FT4 by 0.082 SD (standard error, 0.007; P < .001) but not with incident AF (risk ratio, 0.84; 95% CI, 0.62-1.14; P = .27) or prevalent AF (OR, 1.32; 95% CI, 0.64-2.73; P = .46). Similarly, in summary-level inverse-variance weighted random-effects MR, gene-based FT4 within the reference range was not associated with AF (OR, 1.01; 95% CI, 0.89-1.14; P = .88). However, gene-based increased FT3:FT4 ratio, increased thyrotropin within the reference range, and hypothyroidism were associated with AF with inverse-variance weighted random-effects OR of 1.33 (95% CI, 1.08-1.63; P = .006), 0.88 (95% CI, 0.84-0.92; P < .001), and 0.94 (95% CI, 0.90-0.99; P = .009), respectively, and robust to tests of horizontal pleiotropy. However, the subset of hypothyroidism single-nucleotide polymorphisms involved in autoimmunity and thyroid peroxidase antibodies levels were not associated with AF. Gene-based hyperthyroidism was associated with AF with MR-Egger OR of 1.31 (95% CI, 1.05-1.63; P = .02) with evidence of horizontal pleiotropy (P = .045). Genetically increased FT3:FT4 ratio and hyperthyroidism, but not FT4 within the reference range, were associated with increased AF, and increased thyrotropin within the reference range and hypothyroidism were associated with decreased AF, supporting a pathway involving the pituitary-thyroid-cardiac axis.
Identifiants
pubmed: 30673084
pii: 2722686
doi: 10.1001/jamacardio.2018.4635
pmc: PMC6396813
doi:
Substances chimiques
Triiodothyronine
06LU7C9H1V
Thyrotropin
9002-71-5
Iodide Peroxidase
EC 1.11.1.8
Thyroxine
Q51BO43MG4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
144-152Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL120393
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK089174
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL120393
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL105756
Pays : United States
Organisme : American Heart Association-American Stroke Association
ID : 16EIA26410001
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL116690
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK112940
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL136852
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134811
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Nat Commun. 2015 Mar 06;6:5681
pubmed: 25743335
Int J Endocrinol. 2018 Jun 4;2018:4836736
pubmed: 29971103
Clin Chem. 2008 Feb;54(2):249-55
pubmed: 18070814
Clin Endocrinol (Oxf). 2014 May;80(5):743-50
pubmed: 24304446
Nat Genet. 2016 Jul;48(7):709-17
pubmed: 27182965
J Clin Endocrinol Metab. 2015 May;100(5):E799-807
pubmed: 25719932
PLoS Genet. 2013;9(2):e1003266
pubmed: 23408906
Am J Hum Genet. 2011 Oct 7;89(4):529-42
pubmed: 21981779
Curr Epidemiol Rep. 2017;4(4):330-345
pubmed: 29226067
Stat Med. 2015 Sep 20;34(21):2926-40
pubmed: 25950993
Stat Med. 2017 May 20;36(11):1783-1802
pubmed: 28114746
J Am Coll Cardiol. 2007 Jan 2;49(1):71-81
pubmed: 17207725
Genet Epidemiol. 2016 May;40(4):304-14
pubmed: 27061298
Circulation. 2007 Oct 9;116(15):1725-35
pubmed: 17923583
Am J Epidemiol. 1989 Apr;129(4):687-702
pubmed: 2646917
Clin Endocrinol (Oxf). 2008 Mar;68(3):450-7
pubmed: 17941909
Ann Epidemiol. 1991 Feb;1(3):263-76
pubmed: 1669507
J Clin Endocrinol Metab. 2008 Aug;93(8):3075-81
pubmed: 18492748
PLoS Genet. 2014 Feb 27;10(2):e1004123
pubmed: 24586183
JAMA. 2006 Mar 1;295(9):1033-41
pubmed: 16507804
Nat Genet. 2018 Sep;50(9):1225-1233
pubmed: 29892015
Nat Commun. 2018 Oct 26;9(1):4455
pubmed: 30367059
Stat Med. 2008 Apr 15;27(8):1133-63
pubmed: 17886233
PLoS One. 2012;7(4):e34442
pubmed: 22493691
Behav Genet. 2017 Sep;47(5):480-485
pubmed: 28785901
BMJ. 2012 Nov 27;345:e7895
pubmed: 23186910
Nat Genet. 2017 Jun;49(6):946-952
pubmed: 28416818
Lancet. 2002 Nov 23;360(9346):1623-30
pubmed: 12457784
J Endocrinol. 2011 Jun;209(3):283-97
pubmed: 21415143
Nat Genet. 2012 Jan 22;44(3):319-22
pubmed: 22267200
Eur J Endocrinol. 2017 Jan;176(1):1-9
pubmed: 27697972
Int J Biostat. 2016 Nov 1;12(2):
pubmed: 27092657
J Am Coll Cardiol. 2015 Sep 1;66(9):1000-7
pubmed: 26314526
Circulation. 2017 Nov 28;136(22):2100-2116
pubmed: 29061566